We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+5.83%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$177M
AUM Growth
-$25.3M
Cap. Flow
-$26.9M
Cap. Flow %
-15.18%
Top 10 Hldgs %
37.78%
Holding
91
New
22
Increased
14
Reduced
14
Closed
30

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$4.08M
2
SNY icon
Sanofi
SNY
+$3.58M
3
CI icon
Cigna
CI
+$2.81M
4
ABBV icon
AbbVie
ABBV
+$2.69M
5
AVXS
AveXis, Inc. Common Stock
AVXS
+$2.25M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$8.2M
2
MDCO
Medicines Co
MDCO
+$4.45M
3
SHPG
Shire pic
SHPG
+$3.71M
4
WBA
Walgreens Boots Alliance
WBA
+$2.91M
5
MRK icon
Merck
MRK
+$2.87M

Sector Composition

Rank Sector Weight
1 Healthcare 69.67%
2 Financials 2.79%
3 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$12.7M 7.16%
97,500
+7,500
+8% +$919K
ALXN
2
DELISTED
Alexion Pharmaceuticals
ALXN
$7.3M 4.13%
60,000
+10,000
+20% +$1.16M
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
$7.02M 3.97%
75,000
+25,000
+50% +$1.53M
SHPG
4
DELISTED
Shire pic
SHPG
$6.61M 3.74%
40,000
-21,250
-35% -$3.71M
MRK icon
5
CALL
Merck
MRK
$322B
$6.41M 3.62%
+104,800
New +$6.38M
AGN
6
DELISTED
Allergan plc
AGN
$6.08M 3.44%
25,000
+7,500
+43% +$1.76M
MDCO
7
DELISTED
Medicines Co
MDCO
$5.7M 3.22%
150,000
-100,000
-40% -$4.45M
MRK icon
8
Merck
MRK
$322B
$5.13M 2.9%
83,840
-47,160
-36% -$2.87M
AERI
9
DELISTED
Aerie Pharmaceuticals
AERI
$4.99M 2.82%
95,000
+10,000
+12% +$466K
AET
10
DELISTED
Aetna Inc
AET
$4.93M 2.79%
32,500
-17,500
-35% -$2.47M
KTWO
11
DELISTED
K2M Group Holdings, Inc
KTWO
$4.87M 2.75%
200,000
– –
GBT
12
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.79M 2.71%
175,000
-25,000
-13% -$744K
RARE icon
13
Ultragenyx Pharmaceutical
RARE
$2.46B
$4.66M 2.63%
75,000
– –
ESPR
14
DELISTED
Esperion Therapeutics
ESPR
$4.63M 2.62%
100,000
+25,000
+33% +$919K
SPNC
15
DELISTED
Spectranetics Corp
SPNC
$4.22M 2.39%
110,000
+35,000
+47% +$1.01M
LLY icon
16
Eli Lilly
LLY
$1.08T
$4.12M 2.33%
+50,000
New +$4.08M
DERM
17
DELISTED
Dermira, Inc.
DERM
$4.08M 2.31%
140,000
– –
CLVS
18
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
$3.75M 2.12%
+40,000
New +$2.45M
SNY icon
19
Sanofi
SNY
$107B
$3.59M 2.03%
+75,000
New +$3.58M
AZN icon
20
PUT
AstraZeneca
AZN
$269B
$3.41M 1.93%
+50,000
New +$3.27M
ZBH icon
21
Zimmer Biomet
ZBH
$18.8B
$3.21M 1.81%
25,750
+10,300
+67% +$1.22M
ALXN
22
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
$3.04M 1.72%
25,000
– –
JUNO
23
DELISTED
Juno Therapeutics, Inc.
JUNO
$2.99M 1.69%
100,000
– –
CI icon
24
Cigna
CI
$78.4B
$2.93M 1.66%
+17,500
New +$2.81M
ABBV icon
25
AbbVie
ABBV
$465B
$2.9M 1.64%
+40,000
New +$2.69M
1
2 3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q2 2017 Portfolio in Review

As of Q2 2017, Iguana Healthcare Management held 91 positions worth $177M, down 13% from $202M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Iguana Healthcare Management withdrew a net $26.9M in Q2 2017, closing 30 positions and reducing 14 holdings. Its most notable exit was Amgen, an estimated $8.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 66% a quarter earlier, followed by Financials and Energy.

Against the trend, Iguana Healthcare Management opened a new position in Eli Lilly worth $4.12M.

  • Iguana Healthcare Management's largest Q2 2017 buy was Eli Lilly: 50,000 shares worth $4.12M.
  • Iguana Healthcare Management added most to Allergan plc in Q2 2017, an estimated $1.76M increase.
  • Iguana Healthcare Management's biggest Q2 2017 reduction was Medicines Co, cutting an estimated $4.45M.
  • Iguana Healthcare Management fully exited Amgen in Q2 2017, selling an estimated $8.2M.
  • Iguana Healthcare Management's ten largest holdings make up 38% of its $177M portfolio in Q2 2017.
  • Iguana Healthcare Management opened 22 new positions and closed 30 in Q2 2017.
  • Iguana Healthcare Management's portfolio value fell 13% quarter-over-quarter to $177M.

Based on Iguana Healthcare Management's 13F filing for Q2 2017, filed 14 Aug 2017.